Mitchener Stephen 4
4 · Karyopharm Therapeutics Inc. · Filed Mar 2, 2022
Insider Transaction Report
Form 4
Mitchener Stephen
SVP, Chief Business Officer
Transactions
- Award
Common Stock
2022-02-28+47,250→ 50,546 total - Award
Stock Option (right to buy)
2022-02-28+59,400→ 59,400 totalExercise: $10.33Exp: 2032-02-27→ Common Stock (59,400 underlying)
Footnotes (2)
- [F1]Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2013 Stock Incentive Plan (the "Plan"). RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in four equal annual installments beginning February 28, 2023.
- [F2]This option was granted on February 28, 2022 pursuant to the Plan. The shares underlying this option vest as to 25% of the shares on February 28, 2023, with the remaining 75% vesting in 36 equal monthly installments thereafter.